pharmaceuticals

The important question now is, what's next?

They might be okay, but you probably shouldn't.

In the US, the physician-dispensing landscape is still messy.

A whole universe of non-pathogenic strains built the foundations of modern science.

Understanding desire isn’t easy, and studies that have attempted it have been thoroughly criticized.

Errors happen in drug making. But quality testing helps prevent them from reaching the public.

Americans have unrealistic expectations of how COVID-19 vaccines should be made.

Lower doses could save more lives, some oncologists say.

The tech, which has saved tens of millions of lives over time, keeps getting better.

A new wave of studies convinced the US government to make the drug an option for non-pediatric hospitalized patients.